Impact of SWI/SNF complex mutations in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors: Immuno-oncology biomarker study in LC-SCRUM-Japan (LC-SCRUM-IBIS)

MLA

Kazumi Nishino, et al. “Impact of SWI/SNF Complex Mutations in Patients with Non-Small Cell Lung Cancer (NSCLC) Treated with Immune Checkpoint Inhibitors: Immuno-Oncology Biomarker Study in LC-SCRUM-Japan (LC-SCRUM-IBIS).” Journal of Clinical Oncology, vol. 38, May 2020, p. 9530. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........d0fa765b918a222918c240bef546b591&authtype=sso&custid=ns315887.

APA

Kazumi Nishino, Satoshi Oizumi, Genichiro Ishii, Hidetoshi Itani, Kiyotaka Yoh, Noriko Motoi, Atsushi Nakamura, Naoki Furuya, Yuichiro Hayashi, Koichi Goto, Norio Okamoto, Shingo Matsumoto, Shingo Miyamoto, & Shoichi Kuyama. (2020). Impact of SWI/SNF complex mutations in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors: Immuno-oncology biomarker study in LC-SCRUM-Japan (LC-SCRUM-IBIS). Journal of Clinical Oncology, 38, 9530.

Chicago

Kazumi Nishino, Satoshi Oizumi, Genichiro Ishii, Hidetoshi Itani, Kiyotaka Yoh, Noriko Motoi, Atsushi Nakamura, et al. 2020. “Impact of SWI/SNF Complex Mutations in Patients with Non-Small Cell Lung Cancer (NSCLC) Treated with Immune Checkpoint Inhibitors: Immuno-Oncology Biomarker Study in LC-SCRUM-Japan (LC-SCRUM-IBIS).” Journal of Clinical Oncology 38 (May): 9530. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........d0fa765b918a222918c240bef546b591&authtype=sso&custid=ns315887.